Vaccinex (VCNX) Net earnings per share growth forecast for next year

Symbol and logo of brand Vaccinex, Inc (VCNX)

Vaccinex, Inc. is recognized as an authoritative developer of antibodies for combating oncology and neurodegeneration. This earnings per share forecast chart confirms these expectations, where the value 0.00 represents the current metric. Risks are associated with a narrow focus on a single platform, however, business scalability is ensured through lucrative partnerships with pharmaceutical behemoths.

VCNX - Vaccinex, Inc Earnings growth forecast for next year over the range 07/04/2022 - 12/28/2024

Metric breakdowns and analytics for Vaccinex, Inc (VCNX)

- price and consensus price forecast:
Price Chart vaccinex.com|VCNX - Consensus Target
- market capitalization details:
Market Value Vaccinex, Inc|VCNX - Real Price to Acquire Entire Company
- company book value details:
Accounting Value per Share Vaccinex|VCNX - Book Capitalization|Market Value to Book Value Ratio vaccinex.com|VCNX - Total Business Assets
- company liabilities and liquidity data:
Debt to Equity Vaccinex, Inc.|VCNX - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Vaccinex Inc.|VCNX - Company Total Indebtedness|Debt to Book Value Vaccinex|VCNX - Amount of Long-Term Liabilities|Company Short-Term Debts Vaccinex|Quick Ratio vaccinex.com
- earnings and market ratios statistics:
VCNX - Company Net Income|Expected Profit Vaccinex, Inc.|VCNX - Company Value to Net Income|Forward P/E Multiple vaccinex.com|VCNX - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vaccinex, Inc.|VCNX - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share for the last 12 months Vaccinex|VCNX - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months vaccinex.com|VCNX - Earnings per share growth in current year|Earnings growth forecast for next year Vaccinex, Inc.
- revenue and sales proceeds data:
VCNX - Revenue and Sales Volume|Projected Sales Volume vaccinex.com|VCNX - Market Cap to Revenue|Forward P/S Multiple Vaccinex, Inc
Analysis of all company metrics:Vaccinex, Inc
Core merchandise of Vaccinex Inc.

This indicator captures the mathematical dynamics of consensus forecasts for net income changes, allowing investors to eliminate emotional market interpretations and objectively assess future returns. By analyzing the target net income per share growth rate via GURU.Markets, one can track how breakthroughs in neurodegenerative pathology therapies and the search for strategic partners impact the financial stability of Vaccinex, Inc. (VCNX).

Direct competitors

Net earnings per share growth forecast for next year immunitybio.com|Expected earnings per share growth for next year immunocore.com (IMCR)|Net earnings per share growth forecast for next year Janux Therapeutics Inc (JANX)|Expected earnings per share growth for next year Arcus Bio RCUS|Zymeworks Inc - Expected earnings per share growth for next year|Earnings growth forecast for next year Tango Therapeutics Corp TNGX|IOVA - Net earnings per share growth forecast for next year|IMTX (immatics.com) - Projected earnings per share growth rate for next year|Xencor Inc. (XNCR) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Compass Bio (CMPX)|Expected earnings per share growth for next year REPL|LYEL - Net earnings per one share growth forecast for next year|Expected earnings per share growth for next year IPHA (Innate Pharma, S.A.)|Projected earnings per share increase next year PYXS|Earnings growth forecast for next year CGEN (Compugen Ltd.)|Expected earnings per share trend next year IOBT|sutrobio.com - Earnings growth forecast for next year|Expected net earnings per share growth next year MiNK Therapeutics, Inc|Werewolf (HOWL) - Net earnings per share growth forecast for next year|Immix Biopharma Inc. - Expected earnings per share trend next year|ALXO (alxoncology.com) - Earnings growth forecast for next year|Cue Biopharma, Inc. - Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year pdsbiotech.com (PDSB)|SONN: Net earnings per share change forecast for next year|MAIA Biotech - Expected earnings per share growth for next year|liminatuspharma.com (LIMN) - Expected net earnings per share growth next year|LVTX - Net earnings per share growth forecast for next year|NXTC (NextCure) - Projected earnings per share growth rate for next year|LPTX: Earnings growth forecast for next year|Projected earnings per share growth rate for next year INTS|Net earnings per share growth forecast for next year Sensei Biotherapeutics, Inc.|Expected net earnings per share growth next year therivabio.com TOVX|Expected earnings per share growth for next year GRTS (Gritstone bio, Inc.)|Earnings growth forecast for next year Kineta Bio (KA)|Net earnings per share growth forecast for next year NexImmune Corporation NEXI|Consensus forecast of earnings per share growth for next year turnstonebio.com (TSBX)|HARP - Net earnings per share growth forecast for next year